Recanalization of previously thrombosed type II endoleak with aneurysm sac expansion after systemic thrombolysis

Marcos Takuya Kuroki, Katelynn Ferranti, Faisal Aziz, John Radtka

Research output: Contribution to journalArticle

Abstract

Patients who have undergone endovascular aneurysm repair (EVAR) need lifelong monitoring because of the risk of aneurysm rupture secondary to delayed endoleaks. Thrombolytic therapy may expose patients with previous EVAR to the risk for development of new endoleaks. We describe a case in which a single dose of intravenous tissue plasminogen activator for acute ischemic stroke was complicated by aneurysm sac expansion secondary to a recurrent endoleak. The potential for a life-threatening complication may warrant routine imaging evaluation of the stent graft after systemic tissue plasminogen activator therapy for acute ischemic stroke in patients with previous EVAR.

Original languageEnglish (US)
Pages (from-to)262-264
Number of pages3
JournalJournal of Vascular Surgery Cases and Innovative Techniques
Volume4
Issue number3
DOIs
StatePublished - Sep 1 2018

Fingerprint

Endoleak
Aneurysm
Thrombosis
Tissue Plasminogen Activator
Stroke
Thrombolytic Therapy
Stents
Rupture
Transplants

All Science Journal Classification (ASJC) codes

  • Surgery
  • Cardiology and Cardiovascular Medicine

Cite this

@article{560199cb8339499d947c03b7b9ac17db,
title = "Recanalization of previously thrombosed type II endoleak with aneurysm sac expansion after systemic thrombolysis",
abstract = "Patients who have undergone endovascular aneurysm repair (EVAR) need lifelong monitoring because of the risk of aneurysm rupture secondary to delayed endoleaks. Thrombolytic therapy may expose patients with previous EVAR to the risk for development of new endoleaks. We describe a case in which a single dose of intravenous tissue plasminogen activator for acute ischemic stroke was complicated by aneurysm sac expansion secondary to a recurrent endoleak. The potential for a life-threatening complication may warrant routine imaging evaluation of the stent graft after systemic tissue plasminogen activator therapy for acute ischemic stroke in patients with previous EVAR.",
author = "Kuroki, {Marcos Takuya} and Katelynn Ferranti and Faisal Aziz and John Radtka",
year = "2018",
month = "9",
day = "1",
doi = "10.1016/j.jvscit.2018.05.008",
language = "English (US)",
volume = "4",
pages = "262--264",
journal = "Journal of Vascular Surgery Cases and Innovative Techniques",
issn = "2352-667X",
publisher = "Elsevier BV",
number = "3",

}

Recanalization of previously thrombosed type II endoleak with aneurysm sac expansion after systemic thrombolysis. / Kuroki, Marcos Takuya; Ferranti, Katelynn; Aziz, Faisal; Radtka, John.

In: Journal of Vascular Surgery Cases and Innovative Techniques, Vol. 4, No. 3, 01.09.2018, p. 262-264.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Recanalization of previously thrombosed type II endoleak with aneurysm sac expansion after systemic thrombolysis

AU - Kuroki, Marcos Takuya

AU - Ferranti, Katelynn

AU - Aziz, Faisal

AU - Radtka, John

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Patients who have undergone endovascular aneurysm repair (EVAR) need lifelong monitoring because of the risk of aneurysm rupture secondary to delayed endoleaks. Thrombolytic therapy may expose patients with previous EVAR to the risk for development of new endoleaks. We describe a case in which a single dose of intravenous tissue plasminogen activator for acute ischemic stroke was complicated by aneurysm sac expansion secondary to a recurrent endoleak. The potential for a life-threatening complication may warrant routine imaging evaluation of the stent graft after systemic tissue plasminogen activator therapy for acute ischemic stroke in patients with previous EVAR.

AB - Patients who have undergone endovascular aneurysm repair (EVAR) need lifelong monitoring because of the risk of aneurysm rupture secondary to delayed endoleaks. Thrombolytic therapy may expose patients with previous EVAR to the risk for development of new endoleaks. We describe a case in which a single dose of intravenous tissue plasminogen activator for acute ischemic stroke was complicated by aneurysm sac expansion secondary to a recurrent endoleak. The potential for a life-threatening complication may warrant routine imaging evaluation of the stent graft after systemic tissue plasminogen activator therapy for acute ischemic stroke in patients with previous EVAR.

UR - http://www.scopus.com/inward/record.url?scp=85052514632&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052514632&partnerID=8YFLogxK

U2 - 10.1016/j.jvscit.2018.05.008

DO - 10.1016/j.jvscit.2018.05.008

M3 - Article

C2 - 30186999

AN - SCOPUS:85052514632

VL - 4

SP - 262

EP - 264

JO - Journal of Vascular Surgery Cases and Innovative Techniques

JF - Journal of Vascular Surgery Cases and Innovative Techniques

SN - 2352-667X

IS - 3

ER -